» Articles » PMID: 11237731

A Novel Single Nucleotide Polymorphism Altering Stability and Activity of CYP2a6

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2001 Mar 10
PMID 11237731
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

CYP2A6 is known as a major cytochrome P450 (CYP) responsible for the oxidation of nicotine and coumarin in humans. In this study, we explored genetic polymorphisms, which reduce CYP2A6 activity in Japanese. Two novel mutations in exon 9 of the CYP2A6 gene were found. A single nucleotide polymorphism of T1412C and G1454T resulted in Ile471Thr and Arg485Leu substitution, respectively. The frequency of the former variant allele was considerably high (15.7%), while the latter variant appeared to be a rare polymorphism. Heterologous expression of CYP2A6 using a cDNA possessing C instead of T-base at codon 471 in Escherichia coli caused remarkable reduction of the stability of holoenzyme at 37 degrees C. Furthermore, this variant enzyme almost lacked nicotine C-oxidase activity, although coumarin 7-hydroxylase activity was still observed. These data suggest that individuals homozygous for the T1412C variant allele or heterozygous for this and a defect allele such as the CYP2A6*4 may be poor metabolizer of nicotine, but not coumarin.

Citing Articles

Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.

Perez-Paramo Y, Watson C, Chen G, Thomas C, Adams-Haduch J, Wang R Cancer Epidemiol Biomarkers Prev. 2022; 32(1):54-65.

PMID: 36252563 PMC: 9827107. DOI: 10.1158/1055-9965.EPI-22-0868.


Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective.

Schelstraete W, De Clerck L, Govaert E, Millecam J, Devreese M, Deforce D Sci Rep. 2019; 9(1):9233.

PMID: 31239454 PMC: 6592956. DOI: 10.1038/s41598-019-45212-0.


Effects of polymorphic variation on the thermostability of heterogenous populations of CYP3A4 and CYP2C9 enzymes in solution.

Arendse L, Blackburn J Sci Rep. 2018; 8(1):11876.

PMID: 30089838 PMC: 6082832. DOI: 10.1038/s41598-018-30195-1.


Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.

Lopez-Flores L, Perez-Rubio G, Falfan-Valencia R EXCLI J. 2017; 16:174-196.

PMID: 28507465 PMC: 5427481. DOI: 10.17179/excli2016-847.


Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.

Phompradit P, Muhamad P, Cheoymang A, Na-Bangchang K Am J Trop Med Hyg. 2014; 91(2):361-6.

PMID: 24891466 PMC: 4125263. DOI: 10.4269/ajtmh.13-0531.